Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc

Grade Last Price % Change Price Change
F 3.600 -1.37% -0.050
EPRX closed down 1.35 percent on Tuesday, April 16, 2024, on 59 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish -1.37%
Narrow Range Bar Range Contraction -1.37%
New 52 Week Low Weakness -1.37%
Oversold Stochastic Weakness -1.37%
New 52 Week Low Weakness -2.70%
Outside Day Range Expansion -2.70%
Gapped Up Strength -2.70%
Oversold Stochastic Weakness -2.70%
New 52 Week Closing Low Bearish -2.70%
Calm After Storm Range Contraction -2.70%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low 37 minutes ago
Down 1% 37 minutes ago
Up 1% 37 minutes ago
New 52 Week Low 37 minutes ago
Possible Inside Day about 20 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eupraxia Pharmaceuticals Inc Description

Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate, EP-104IAR, that is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treatment of canine and equine osteoarthritis. Its products in development also include EP-201, a product candidate for prophylaxis of post-surgical infections; and EP-105, an extended-release product candidate for the local delivery of anesthetics to treat post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was founded in 2012 and is headquartered in Victoria, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pain Life Sciences Arthritis Osteoarthritis Skeletal Disorders

Is EPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.1
52 Week Low 3.6
Average Volume 73,999
200-Day Moving Average 6.350
50-Day Moving Average 5.384
20-Day Moving Average 4.045
10-Day Moving Average 3.823
Average True Range 0.323
RSI (14) 31.51
ADX 19.3
+DI 21.355
-DI 20.822
Chandelier Exit (Long, 3 ATRs) 3.842
Chandelier Exit (Short, 3 ATRs) 4.568
Upper Bollinger Bands 4.587
Lower Bollinger Band 3.503
Percent B (%b) 0.14
BandWidth 26.802
MACD Line -0.422
MACD Signal Line -0.459
MACD Histogram 0.0365
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.860
Resistance 3 (R3) 3.867 3.803 3.825
Resistance 2 (R2) 3.803 3.750 3.800 3.813
Resistance 1 (R1) 3.727 3.717 3.695 3.720 3.802
Pivot Point 3.663 3.663 3.648 3.660 3.663
Support 1 (S1) 3.587 3.610 3.555 3.580 3.498
Support 2 (S2) 3.523 3.577 3.520 3.487
Support 3 (S3) 3.447 3.523 3.475
Support 4 (S4) 3.440